Health Condition 1: L210- Seborrhea capitis
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Silphion Research Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Have clinical diagnosis of dandruff Are willing to follow the treatment protocol Provide written informed consent
Exclusion criteria
Exclusion criteria: Patients with Scalp psoriasis Patients with Tinea capitis Severe seborrheic dermatitis requiring systemic therapy Known hypersensitivity to product ingredients Use of other medicated anti-dandruff treatments during the study period Participation in another clinical study Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in DSI score from baseline to week 4Timepoint: baseline, week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in individual components of DSI Physician satisfaction score (VAS) Proportion of patients showing improvement in severity category Safety observationsTimepoint: baseline, week 4 | — |
Countries
India
Contacts
Public ContactDr T Vanathi
RENDER SKIN AND HAIR
Outcome results
None listed